COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Sarah Skoczen

Sarah Skoczen, M.S.Sarah Skoczen, MS
Research Associate III, Pharmacology & Toxicology

Ms. Skoczen is a member of the pharmacology and toxicology section of the Nanotechnology Characterization Laboratory, with over 15 years of experience in preclinical cancer research. Her expertise includes the development of small molecule bioanalytical assays utilizing triple quadrapole and quadropole-orbitrap mass spectrometry to support drug metabolism and pharmacokinetic studies. Recently, Mrs. Skoczen’s work has focused on the advancement of novel nanomedicine drug release methods using stable isotope tracers to quantify encapsulated and unencapsulated drug fractions in biological matrices, with application to formulation optimization and generic bioequivalence. Mrs. Skoczen received a B.S. in biology from Shippensburg University and a M.S. in biotechnology from Johns Hopkins University.